ALMKT:EPA
Mauna Kea Technologies SA
0,093 €
arrow_downward
-1,90%(-0,0018) 1D
3 nën, 10:16:47 p.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,09 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
17,61 mln
Vëllimi mesatar
495,55 mijë
Vëllimi
384,93 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Hap
0,09 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
17,61 mln
Vëllimi mesatar
495,55 mijë
Vëllimi
384,93 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ChartMill
·
34 minuta më parë
Acadia Healthcare (NASDAQ:ACHC) Meets a Breakout Setup With Strong Technicals
FXStreet
·
24 minuta më parë
Trading the US Midterm elections, Gold? USD? Nasdaq? AUD/USD lower on RBA interest rates [Video]
Yahoo Finance
·
54 minuta më parë
Broadridge Signs On to Run Shareholder Votes for NYSE’s Planned Tokenized Stocks
Seeking Alpha
·
3 orë më parë
The Midterm Election Rally: What 19 Election Cycles Reveal About the S&P 500
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriMedical device
Uebsajtimaunakeatech.com